Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modulation of T-cell function by gliomas.

T Roszman1, L Elliott, W Brooks

  • 1Dept of Microbiology and Immunology, University of Kentucky Medical Center, Lexington 40536.

Immunology Today
|October 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Light Pseudoscalar Bosons, Pair-Produced in Higgs Boson Decays in the Four-Electron Final State in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

Observation of Suppressed Charged-Particle Production in Ultrarelativistic Oxygen-Oxygen Collisions.

Physical review letters·2026
Same author

Observation of tWZ Production at the CMS Experiment.

Physical review letters·2026
Same author

First Exclusive Reconstruction of the B^{*+}, B^{*0}, and B_{s}^{*0} Mesons and Precise Measurement of Their Masses.

Physical review letters·2026
Same author

Simultaneous Probe of the Charm and Bottom Quark Yukawa Couplings Using tt[over ¯]H Events.

Physical review letters·2026
Same author

Reconsidering Governance Models to Strengthen Rural Healthcare.

Journal of bioethical inquiry·2025
Same journal

Foreword.

Immunology today·2020
Same journal

The origin and significance of anti-DNA antibodies.

Immunology today·2014
Same journal

Mutations of class II MHC molecules.

Immunology today·2014
Same journal

Antigen processing at the molecular level.

Immunology today·2014
Same journal

Phenotypically and functionally distinct T-cell subsets in anti-tumor responses.

Immunology today·2014
Same journal

Are MHC class II-restricted cytotoxic T lymphocytes important?

Immunology today·2014
See all related articles

Gliomas in patients cause severe immune system decline by impairing T cells' ability to secrete interleukin 2 and express IL-2 receptors. Researchers identified immunosuppressive factors from gliomas as the cause of these T cell defects.

Area of Science:

  • Neuro-oncology
  • Immunology
  • Cellular Biology

Background:

  • Primary intracranial tumors, specifically gliomas, are associated with a significant reduction in patient immunity.
  • The underlying mechanisms driving this immunosuppression have not been fully elucidated.

Purpose of the Study:

  • To investigate the immunological defects in T cells from glioma patients.
  • To identify the role of glioma-derived factors in causing these T cell dysfunctions.

Main Methods:

  • Analysis of T cells isolated from patients with primary intracranial tumors (gliomas).
  • Assessment of interleukin 2 (IL-2) secretion levels.
  • Evaluation of high-affinity IL-2 receptor expression on T cells.

Main Results:

Related Experiment Videos

  • T cells from glioma patients demonstrated impaired interleukin 2 secretion.
  • A decrease in the expression of the high-affinity IL-2 receptor was observed in these T cells.
  • Evidence suggests immunosuppressive factors produced by gliomas contribute to these T cell defects.

Conclusions:

  • Glioma-associated immunosuppression involves specific defects in T cell function, including reduced IL-2 production and IL-2 receptor expression.
  • Immunosuppressive factors secreted by gliomas play a critical role in inducing these T cell impairments, contributing to the overall decrease in immunity observed in patients.